to readers

1
Antibiogram 2002-2009 in Washoe County Nevada – Know the Local Data, Prevent Antimicrobial Resistance Lei Chen, Ph.D., Senior Epidemiologist, Washoe County Health District, Reno, Nevada. Email: [email protected] TO READERS This antibiogram was compiled by the Division of Epidemiology & Public Health Preparedness (DEPHP), Washoe County Health District in collaboration with all four hospital laboratories in the community. Data covered all inpatients in local hospitals and outpatients seen at hospital emergency rooms. This antibiogram can be used as a reference for clinicians but shouldn't serve as a basis for therapy. The antibiotic susceptibility test for individual patients is still encouraged, if needed. This antibiogram only represents antibiotic susceptibility in vitro. Please address your questions, comments, and/or suggestions to DEPHP at 775-328-2447 or e-mail to [email protected] . The online version and pocket size version can be downloaded from the Health Department’s website at www.washoecounty.us/health/cdpp/warr.html ACKNOWLEDGEMENTS Northern Nevada Medical Center Laboratory, Renown Regional Medical Center Laboratory, Saint Mary’s Regional Medical Center Laboratory, Veteran’s Affairs Medical Center Laboratory (Reno). To read this antibiogram : 1) Each organism is presented in two rows. The top row represents susceptibility in percent to that antibiotic. The 2nd row represents number of isolates tested for that specific antibiotic. 2) Susceptibility greater than or equal to 90% is highlighted in light GREEN, 60%-89% in YELLOW, and less than 60% in RED. 3) Nitrofurantoin is tested for urine specimens only. 4) The susceptibility result for Streptococcus pneumoniae is a combination of screening test and E-test results. 5) CLSI performance standards for antimicrobial susceptibility testing were applied. CLSI stands for Clinical and Laboratory Standards Institute (Formerly NCCLS, The National Committee for Clinical Laboratory Standards). 6) Black empty shaded cells indicate that susceptibility testing for that specific organism is not recommended or complete testing data was not available or number is too small for valid reporting. ANTIBIOTIC SUSCEPTIBILITY (%) TREND, 2002-2009, WASHOE COUNTY (Published December, 2010) To read these graphs : Each graph represents an organism; X-axis represents the abbreviation of an antibiotic (see tables above graphs for full name of antibiotics); Y- axis represents susceptibility in percent; legends indicate each year and number of isolates identified for that year in parentheses. Attention! Readers should be aware that resistance rate calculation for 2004 from some hospitals was different compared to prior years due to removing duplicates in 2004. Susceptibility result for Acinetobacter Baumanii was available in 2006, 2007, and 2009 therefore only three year trend data was available. Antibiogram 2005 and 2008 were not available. # Isolates identified Am picillin (Am ) Am ikacin (A k) Am oxicillin/clavulanate (A ug) Am picillin/sulbactam (A/S) C efazolin (C fz) Cefotaxim e (C ft)-N on-m eningitis Cefotaxim e (C ft)-M eningitis C eftriaxone (C ax) Clindam ycin (C d) C iprofloxacin (Cp) E rythrom ycin (E) G atifloxacin (G at) Gentam icin (G m ) Gentam icin 500 (G m 500) Im ipenem (Im p)/M eropenem (M er) Levofloxacin (Lvx) Linezolid (Lzd) N itrofurantoin (Fd) Norfloxacin (N OR ) Oxacillin (O x) P enicillin-G (P) R ifam pin (R /F) S treptom ycin 2000 (S T2000) Tetracycline (Te) Trim ethoprim /sulfa (T/S) Vancom ycin (Va) 99% 56% 15% 67% 58% 100% 100% 99% 73% 72% 16% 99% 748 169 484 95 169 380 169 748 116 95 653 748 22% 8% 100% 97% 19% 4% 69% 34% 33% 162 124 29 73 158 25 26 133 162 88% 966 55% 76% 52% 42% 59% 98% 49% 100% 95% 53% 12% 100% 94% 99% 100% 930 1693 1271 1947 254 1472 307 815 86 2033 1184 762 1103 2033 2033 58% 100% 52% 16% 74% 77% 100% 31 31 31 31 31 31 31 25% 53% 25% 24% 56% 69% 28% 98% 100% 29% 14% 100% 83% 53% 100% 255 293 314 352 59 314 118 156 59 411 94 97 156 411 411 89% 79% 69% 97% 75% 95% 91% *** 70% 100% 103 101 112 67 57 63 135 77 111 * E nterococcus faecalis and E nterococcus faecium ** Data from W as hoe C ounty Health Dis tric t's s urveillanc e projec t *** Non-meningitis break point # Isolates identified Am picillin (Am ) Am ikacin (A k) Am oxicillin/clavulanate (A ug) Am picillin/sulbactam (A/S) Aztreonam (A zt) Cefepim e (C pm ) Cefazolin (C fz) Cefuroxim e (C rm ) Cefotaxim e (C ft) C efoxitin (C fx) C eftazidim e (C az) C eftriaxone (C ax) C ephalothin (C f) C iprofloxacin (Cp) G atifloxacin (G at) Gentam icin (G m ) Im ipenem (Im p) Levofloxacin (Lvx) N alidixic Acid (N A) N itrofurantoin (Fd) P iperacillin (P i) Piperacillin-tazobactam (P /T) Tetracycline (Te) Ticarcillin/clavulanate (T/C ) Tobram ycin (To) Trim ethoprim /sulfa (T/S) 68% 64% 79% 93% 96% 93% 79% 28 28 28 28 28 28 28 27% 7% 73% 86% 89% 89% 93% 100% 84% 73% 93% 77% 44 44 44 44 44 44 44 44 44 44 44 44 4% 9% 73% 84% 88% 99% 100% 100% 100% 100% 91% 98% 97% 51 68 51 51 68 68 68 68 25 68 43 51 68 9% 100% 27% 77% 5% 31% 72% 70% 88% 97% 98% 95% 79% 71% 98% 94% 141 30 30 30 153 141 141 153 153 153 153 42 153 111 141 153 53% 100% 85% 58% 97% 95% 91% 93% 100% 98% 94% 82% 89% 100% 82% 97% 97% 73% 89% 82% 75% 2717 1517 759 1005 892 1271 2717 2205 759 2301 2717 2717 2717 2717 1517 1122 2717 1200 646 2717 2717 4% 44% 82% 95% 92% 96% 100% 100% 89% 82% 100% 97% 92 92 92 92 92 92 92 92 92 78 92 92 3% 99% 97% 82% 98% 99% 97% 89% 99% 98% 98% 86% 95% 98% 100% 96% 64% 97% 90% 95% 97% 94% 578 224 150 224 160 150 578 506 150 442 506 86 578 578 578 296 144 578 282 86 506 578 9% 100% 9% 100% 5% 5% 14% 86% 7% 57% 37% 100% 63% 50% 31% 89% 21% 80% 34% 35 21 35 35 21 21 14 35 14 35 35 35 35 14 35 35 14 35 35 66% 98% 69% 99% 78% 80% 99% 99% 51% 85% 96% 59% 99% 67% 61% 189 100 68 68 189 157 157 157 189 189 157 100 189 189 189 93% 69% 78% 16% 84% 21% 70% 84% 84% 63% 93% 72% 95% 266 266 261 71 580 329 580 580 580 261 580 71 524 0% 1% 83% 86% 90% 97% 97% 83% 7% 94% 96% 70 70 70 70 70 70 70 70 58 70 70 41% 100% 42 42 * 2007-2009 data w as notavailable.This row represents 2006 data. Organism Organism G ram N egative A cinetobacter Baumanii E nterobacter aerogenes E nterobacter cloacae E scherichia coli P roteus mirabilis G ram P ositive E nterococcus faecalis E nterococcus faecium S taphylococcus aureus S taphylococcus spp. C oag neg S taphylococcus E pidermidis S treptococcus pneumoniae** 2033 Klebsiella oxytoca K lebsiella pneumoniae 31 S tenotrophomonas maltophilia C itrobacter freundii 44 68 578 189 580 2717 92 966 ANTIBIO G RAM 2009,W ASHOE CO UNTY 35 411 224 28 E nterococcus species* 748 162 153 S erratia marcescens Morganella morganii* P seudomonas aeruginosa 42 70 E. feacalis E. faecium S. aureus S. coagulase neg. S. epidermidis S. pneumoni ae E. cloacae C. freundii E. aerogenes K. pneumoni ae E. coli K. oxytoca S. marcescens M. morganii P. mi rabi l i s P. aeruginosa S. maltophilia SUM M ARY O F M A JO R FIND IN G S DRSP ESBLs & CRE The rate of drug-resistant S treptococcus pneumoniae (D RSP) decreased in the past several years in W ashoe C ounty. The rate for penicillin non-susceptible streptococcus pneumoniae (PNSSP) decreased from 29% in 2002 to 23% in 2007, a 21% decrease, w hich did not show a statistical significance (X 2 = 5.562, P =0.234). The decrease m ight be associated w ith the introduction of pneum ococcal conjungate vaccine in 2000. The resistance to erythrom ycin and gatifloxacin w as 31% and 3% , respectively, in 2009. The rate forP N S S P w as significantly decreased to 9% in 2009 from 23% in 2007, this w as associated w ith C LS I standard change in 2008 to separate breakpoints form eningitis and non-m eningitis. S trains of K lebsiella spp., E . coli, P roteus mirabilis that produce extended-spectrum beta-lactam ase (E S B Ls)m ay be clinically resistant to therapy w ith penicillins, cephalosporins, oraztreonam , despite apparant in vitro susceptibility to som e of these agents. E S B L screening data reported from one laboratory show ed 2.3% of E . coli/K lebsiella spp./Proteus mirabilis produced E S B Ls. The rate of carbapenem - resistant enterobacteriaceae (C R E )w as 0.7% (26/3879)in 2009. A n enhanced surveillance forC R E began in June 2010 and is ongoing in W ashoe C ounty. The rate of vancom ycin-resistant enterococci (V R E )increased from 9.8% in 2002 to 11.6% in 2007, w hich show ed a statistical significance (X 2 = 65, P <0.001). The V R E rate w as 11.9% in 2009, no statistical difference com pared to 11.6% in 2007 (X 2 =0.0255, P =0.87) The rate ofM ethicillin-resistant S taphylococcus aureus (MR SA)significantly increased from 35% in 2002 to 48% in 2007,a 37% increase from 2002 to 2007,w hich show ed a statistical significance (X 2 = 145,P<0.001).The M R SA rate w as 47% in 2009,no statistical difference com pared to 48% in 2007 (X 2 =0.8545,P=0.36). V ancom ycin-interm ediate resistant S taphylococcus aureus (V ISA )or V ancom ycin-resistant S taphylococcus aureus (V R S A) has not been found yet in W ashoe C ounty. P lease report V IS A orV R S A to the W ashoe C ountyH ealth D istrict at 775-328-2447 . P lease also have yourlaboratory save the V IS A /V R S A isolate forfurtherconfirm ation at N evada S tate P ublic H ealth Laboratory. VRE MRSA VISA /VRSA P. aeruginosa 0 20 40 60 80 100 Ak Caz Cpm Gm Imp Lvx P/T To 2002 (1097) 2003 (1180) 2004 (1042) 2006 (742) 2007 (427) 2009 (580) S . maltophilia 0 20 40 60 80 100 Ak Caz Gm Lvx To T/S 2002 (66) 2003 (109) 2004 (44) 2006 (31) 2007 (41) 2009 (42) S . marcescens 0 20 40 60 80 100 Am Cfz Cp Cpm Gm Imp P/T To T/S 2002 (157) 2003 (152) 2004 (118) 2006 (93) 2007 (43) 2009 (70) E . feacalis 0 20 40 60 80 100 P E Fd Te Van 2002 (1282) 2003 (1517) 2004 (1147) 2006 (555) 2007 (607) 2009 (748) E . faecium 0 20 40 60 80 100 P E Fd Te Van 2002 (254) 2003 (230) 2004 (216) 2006 (118) 2007 (131) 2009 (162) S . aureus 0 20 40 60 80 100 Cfz Cd E Gm Lvx Ox P Te T/S Van 2002 (3059) 2003 (3440) 2004 (3660) 2006 (4369) 2007 (2030) 2009 (2033) S . coagulase neg. 0 20 40 60 80 100 Cfz Cd E Gm Lvx Ox P Te T/S V an 2002 (272) 2003 (226) 2004 (336) 2006 (414) 2007 (33) 2009 (31) S . epidermidis 0 20 40 60 80 100 Cfz Cd E Gm Lvx Ox P Te T/S V an 2002 (1004) 2003 (1002) 2004 (800) 2006 (430) 2007 (372) 2009 (411) S . pneumoniae 0 20 40 60 80 100 Cft E G at P V an 2002 (301) 2003 (308) 2004 (297) 2006 (185) 2007 (184) 2009 (224) C . freundii 0 20 40 60 80 100 Am Cfz Cp C pm Gm Imp P/T To T/S 2002 (144) 2003 (211) 2004 (165) 2006 (139) 2007 (39) 2009 (44) E . aerogenes 0 20 40 60 80 100 Am Cfz Cp C pm Gm Imp P/T To T/S 2002 (140) 2003 (191) 2004 (165) 2006 (110) 2007 (32) 2009 (68) E . cloacae 0 20 40 60 80 100 Am Cfz Cp C pm Gm Imp P/T To T/S 2002 (362) 2003 (361) 2004 (318) 2006 (306) 2007 (118) 2009 (153) E . coli 0 20 40 60 80 100 Am Cfz Cp Cpm Gm Imp P/T To T/S 2002 (6018) 2003 (6796) 2004 (7697) 2006 (8040) 2007 (2482) 2009 (2717) K. oxytoca 0 20 40 60 80 100 Am Cfz Cp Cpm Gm Imp P/T To T/S 2002 (205) 2003 (193) 2004 (157) 2006 (119) 2007 (87) 2009 (92) K . pneumoniae 0 20 40 60 80 100 Am Cfz Cp C pm Gm Imp P/T To T/S 2002 (705) 2003 (1272) 2004 (1125) 2006 (1236) 2007 (463) 2009 (578) M. morganii 0 20 40 60 80 100 Am Cfz Cp Cpm Gm Imp P/T To T/S 2002 (56) 2003 (72) 2004 (65) 2006 (35) 2007 (NA ) 2009 (NA ) P. mirabilis 0 20 40 60 80 100 Am Cfz Cp Cpm Gm Imp P/T To T/S 2002 (285) 2003 (455) 2004 (452) 2006 (503) 2007 (121) 2009 (189) A . baumanii 0 20 40 60 80 100 Ak C az C ax Cp Gm Imp To T/S 2002 (NA ) 2003 (NA ) 2004 (NA ) 2006 (32) 2007 (136) 2009(28) RESULT RESULT Antibiogram is an overall profile of antimicrobial susceptibility of a microbial species to a battery of antimicrobial agents. One of the 12 steps to prevent antimiobial resistance in various healthcare settings recommended by CDC is to encourage clinicians to use local data. Since 2002, Washoe County Health District (WCHD) has been collaborating with local laboratories to produce an aggregated community-wide antibiogram every year. Antibiogram has been well received by local medical community. The objectives of this paper are: to summarize findings on major drug resistant organism such as Methicillin- resistant staphylococcus aureus (MRSA), Vancomycin-resistant enterococci (VRE), drug-resistant streptococcus pneumoniae (DRSP), extended-spectrum beta-lactamase (ESBLs), and carbapenem resistant enterobacteriaceae (CRE); to present detailed antibiotic susceptibility data and their trends on 18 commonly seen organisms in healthcare setting for 2002-2009. BACKGROUND BACKGROUND Between 2002 and 2006, WCHD collected institutional antibiograms from local laboratories every year. Between 2007 and present, only local clinical laboratories provided such data. An excel template was developed for each organism to covert susceptibility percent to the number of isolates susceptible and then aggregate them together to produce an overall antibiotic susceptibility percentage. Number of isolates tested less than 10 was excluded from data conversion process. Aggregated number of isolates less than 30 was excluded from final calculation and therefore not reported. All isolates reported represented inpatients seen in local hospitals and outpatients seen in emergency departments. The resistance rate comparison between years was assessed by Chi- square statistics using OpenEpi Program. METHODS METHODS The antibiotic resistant rate increased significantly between 2002 and 2007 but was stable between 2007 and 2009. The rates of ESBLs and CRE were low in Washoe County. CONCLUSIONS CONCLUSIONS

Upload: gypsy

Post on 12-Feb-2016

80 views

Category:

Documents


0 download

DESCRIPTION

Antibiogram 2002-2009 in Washoe County Nevada – Know the Local Data, Prevent Antimicrobial Resistance Lei Chen, Ph.D., Senior Epidemiologist, Washoe County Health District, Reno, Nevada. Email: [email protected]. BACKGROUND. RESULT. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: TO READERS

Antibiogram 2002-2009 in Washoe County Nevada – Know the Local Data, Prevent Antimicrobial ResistanceLei Chen, Ph.D., Senior Epidemiologist, Washoe County Health District, Reno, Nevada. Email: [email protected]

TO READERS

This antibiogram was compiled by the Division of Epidemiology & Public Health Preparedness (DEPHP), Washoe County Health District in collaboration with all four hospital laboratories in the community. Data covered all inpatients in local hospitals and outpatients seen at hospital emergency rooms. This antibiogram can be used as a reference for clinicians but shouldn't serve as a basis for therapy. The antibiotic susceptibility test for individual patients is still encouraged, if needed. This antibiogram only represents antibiotic susceptibility in vitro. Please address your questions, comments, and/or suggestions to DEPHP at 775-328-2447 or e-mail to [email protected]. The online version and pocket size version can be downloaded from the Health Department’s website at www.washoecounty.us/health/cdpp/warr.html

ACKNOWLEDGEMENTSNorthern Nevada Medical Center Laboratory, Renown Regional Medical Center Laboratory, Saint Mary’s Regional Medical Center Laboratory, Veteran’s Affairs Medical Center Laboratory (Reno).

To read this antibiogram: 1) Each organism is presented in two rows. The top row represents susceptibility in percent to that antibiotic. The 2nd row represents number of isolates tested for that specific antibiotic. 2) Susceptibility greater than or equal to 90% is highlighted in light GREEN, 60%-89% in YELLOW, and less than 60% in RED. 3) Nitrofurantoin is tested for urine specimens only. 4) The susceptibility result for Streptococcus pneumoniae is a combination of screening test and E-test results. 5) CLSI performance standards for antimicrobial susceptibility testing were applied. CLSI stands for Clinical and Laboratory Standards Institute (Formerly NCCLS, The National Committee for Clinical Laboratory Standards). 6) Black empty shaded cells indicate that susceptibility testing for that specific organism is not recommended or complete testing data was not available or number is too small for valid reporting.

ANTIBIOTIC SUSCEPTIBILITY (%) TREND, 2002-2009, WASHOE COUNTY (Published December, 2010)

To read these graphs: Each graph represents an organism; X-axis represents the abbreviation of an antibiotic (see tables above graphs for full name of antibiotics); Y-axis represents susceptibility in percent; legends indicate each year and number of isolates identified for that year in parentheses. Attention! Readers should be aware that resistance rate calculation for 2004 from some hospitals was different compared to prior years due to removing duplicates in 2004. Susceptibility result for Acinetobacter Baumanii was available in 2006, 2007, and 2009 therefore only three year trend data was available. Antibiogram 2005 and 2008 were not available.

# Is

olat

es id

entif

ied

Am

pici

llin

(Am

)

Am

ikac

in (A

k)

Am

oxic

illin

/cla

vula

nate

(Aug

)

Am

pici

llin/

sulb

acta

m (A

/S)

Cef

azol

in (C

fz)

Cef

otax

ime

(Cft)

- N

on-m

enin

gitis

Cef

otax

ime

(Cft)

- M

enin

gitis

Cef

triax

one

(Cax

)

Clin

dam

ycin

(Cd)

Cip

roflo

xaci

n (C

p)

Ery

thro

myc

in (E

)

Gat

iflox

acin

(Gat

)

Gen

tam

icin

(Gm

)

Gen

tam

icin

500

(Gm

500

)

Imip

enem

(Im

p) /

Mer

open

em (M

er)

Levo

floxa

cin

(Lvx

)

Line

zolid

(Lzd

)

Nitr

ofur

anto

in (F

d)

Nor

floxa

cin

(NO

R)

Oxa

cilli

n (O

x)

Pen

icill

in-G

(P)

Rifa

mpi

n (R

/F)

Stre

ptom

ycin

200

0 (S

T200

0)

Tetra

cycl

ine

(Te)

Trim

etho

prim

/sul

fa (T

/S)

Van

com

ycin

(Va)

99% 56% 15% 67% 58% 100% 100% 99% 73% 72% 16% 99%

748 169 484 95 169 380 169 748 116 95 653 748

22% 8% 100% 97% 19% 4% 69% 34% 33%

162 124 29 73 158 25 26 133 162

88%

966

55% 76% 52% 42% 59% 98% 49% 100% 95% 53% 12% 100% 94% 99% 100%

930 1693 1271 1947 254 1472 307 815 86 2033 1184 762 1103 2033 2033

58% 100% 52% 16% 74% 77% 100%

31 31 31 31 31 31 31

25% 53% 25% 24% 56% 69% 28% 98% 100% 29% 14% 100% 83% 53% 100%

255 293 314 352 59 314 118 156 59 411 94 97 156 411 411

89% 79% 69% 97% 75% 95% 91%*** 70% 100%

103 101 112 67 57 63 135 77 111* Enterococcus faecalis and Enterococcus faecium ** Data from Washoe County Health District's surveillance project *** Non-meningitis breakpoint

# Is

olat

es id

entif

ied

Am

pici

llin

(Am

)

Am

ikac

in (A

k)

Am

oxic

illin

/cla

vula

nate

(Aug

)

Am

pici

llin/

sulb

acta

m (A

/S)

Azt

reon

am (A

zt)

Cef

epim

e (C

pm)

Cef

azol

in (C

fz)

Cef

urox

ime

(Crm

)

Cef

otax

ime

(Cft)

Cef

oxiti

n (C

fx)

Cef

tazi

dim

e (C

az)

Cef

triax

one

(Cax

)

Cep

halo

thin

(Cf)

Cip

roflo

xaci

n (C

p)

Gat

iflox

acin

(Gat

)

Gen

tam

icin

(Gm

)

Imip

enem

(Im

p)

Levo

floxa

cin

(Lvx

)

Nal

idix

ic A

cid

(NA

)

Nitr

ofur

anto

in (F

d)

Pip

erac

illin

(Pi)

Pip

erac

illin

-tazo

bact

am (P

/T)

Tetra

cycl

ine

(Te)

Tica

rcill

in/c

lavu

lana

te (T

/C)

Tobr

amyc

in (T

o)

Trim

etho

prim

/sul

fa (T

/S)

68% 64% 79% 93% 96% 93% 79%

28 28 28 28 28 28 28

27% 7% 73% 86% 89% 89% 93% 100% 84% 73% 93% 77%

44 44 44 44 44 44 44 44 44 44 44 44

4% 9% 73% 84% 88% 99% 100% 100% 100% 100% 91% 98% 97%

51 68 51 51 68 68 68 68 25 68 43 51 68

9% 100% 27% 77% 5% 31% 72% 70% 88% 97% 98% 95% 79% 71% 98% 94%

141 30 30 30 153 141 141 153 153 153 153 42 153 111 141 153

53% 100% 85% 58% 97% 95% 91% 93% 100% 98% 94% 82% 89% 100% 82% 97% 97% 73% 89% 82% 75%

2717 1517 759 1005 892 1271 2717 2205 759 2301 2717 2717 2717 2717 1517 1122 2717 1200 646 2717 2717

4% 44% 82% 95% 92% 96% 100% 100% 89% 82% 100% 97%

92 92 92 92 92 92 92 92 92 78 92 92

3% 99% 97% 82% 98% 99% 97% 89% 99% 98% 98% 86% 95% 98% 100% 96% 64% 97% 90% 95% 97% 94%

578 224 150 224 160 150 578 506 150 442 506 86 578 578 578 296 144 578 282 86 506 578

9% 100% 9% 100% 5% 5% 14% 86% 7% 57% 37% 100% 63% 50% 31% 89% 21% 80% 34%

35 21 35 35 21 21 14 35 14 35 35 35 35 14 35 35 14 35 35

66% 98% 69% 99% 78% 80% 99% 99% 51% 85% 96% 59% 99% 67% 61%

189 100 68 68 189 157 157 157 189 189 157 100 189 189 189

93% 69% 78% 16% 84% 21% 70% 84% 84% 63% 93% 72% 95%

266 266 261 71 580 329 580 580 580 261 580 71 524

0% 1% 83% 86% 90% 97% 97% 83% 7% 94% 96%

70 70 70 70 70 70 70 70 58 70 70

41% 100%

42 42* 2007-2009 data was not available. This row represents 2006 data.

Organism

Organism

Gra

m N

egat

ive

Acinetobacter Baumanii

Enterobacter aerogenes

Enterobacter cloacae

Escherichia coli

Proteus mirabilis

Gra

m P

ositi

ve

Enterococcus faecalis

Enterococcus faecium

Staphylococcus aureus

Staphylococcus spp. Coag neg

Staphylococcus Epidermidis

Streptococcus pneumoniae**

2033

Klebsiella oxytoca

Klebsiella pneumoniae

31

Stenotrophomonas maltophilia

Citrobacter freundii 44

68

578

189

580

2717

92

966

ANTIBIOGRAM 2009, WASHOE COUNTY

35

411

224

28

Enterococcus species*

748

162

153

Serratia marcescens

Morganella morganii*

Pseudomonas aeruginosa

42

70

E . f eac al i s

0

100

P E Fd Te Van

2001 (1052)

2002 (1282)

2003 (1517)

E . f aec i um

0

100

P E Fd T e Van

2001 (187)

2002 (254)

2003 (230)

S. aur eus

050

100

Cfz Cd E Gm Lvx Ox P Te T/S Van

2001 (2919)

2002 (3059)

2003 (3440)

S. coagulase neg.

050

100

Cfz Cd E Gm Lvx Ox P Te T/S Van

2001 (360)

2002 (272)

2003 (226)

S. epi der mi di s

050

100

Cfz Cd E Gm Lvx Ox P Te T/S Van

2001 (995)

2002 (1004)

2003 (1002)

S . pn eumon iae

0

50

100

Cft E Gat P Van

2001 (338)

2002 (301)

2003 (308)

E . c l oac ae

050

100

Am Cfz Cp Gm To T/S

2001

2002 (362 )

2003 (361)

C . f r eundi i

050

100

Am Cfz Cp Gm To T/S

2001

2002 (144)

2003 (211)

E . aer ogen es

0

50

100

Am Cfz Cp Gm To T/S

2001

2002 (140)

2003 (191)

K . pn eumon iae

0

50

100

Am Cfz Cp Gm To T/S

2001 (1045)

2002 (705)

2003 (1272)

E . c ol i

050

100

Am Cfz Cp Gm To T/S

2001 (5587)

2002 (6018)

2003 (6796)

K . oxytoc a

0

50

100

Am Cfz Cp Gm To T/S

2001

2002 (205)

2003 (193)

S. mar c es c ens

050

100

Am Cfz Cp Gm To T/S

2001

2002 (157)

2003 (152)

M . mor gani i

050

100

Am Cfz Cp Gm To T/S

2001

2002 (56)

2003 (72)

P . mir abilis

0

50

100

Am Cfz Cp Gm To T/S

2001

2002 (285)

2003 (455)

P . aer ugi nos a

050

100

Ak Caz Cft Gm Lvx P/T To

2001 (968)

2002 (1097)

2003 (1180)

S. mal tophi l i a

0

50

100

Ak Caz Cft Gm Lvx To T/S

2001

2002 (66)

2003 (109)

SUMMARY OF MAJOR FINDINGS

DRSP

ESBLs & CRE

The rate of drug-resistant Streptococcus pneumoniae (DRSP) decreased in the past several years in Washoe County. The rate for penicillin non-susceptible streptococcus pneumoniae (PNSSP) decreased from 29% in 2002 to 23% in 2007, a 21% decrease, which did not show a statistical significance (X2 = 5.562, P=0.234). The decrease might be associated with the introduction of pneumococcal conjungate vaccine in 2000. The resistance to erythromycin and gatifloxacin was 31% and 3%, respectively, in 2009. The rate for PNSSP was significantly decreased to 9% in 2009 from 23% in 2007, this was associated with CLSI standard change in 2008 to separate breakpoints for meningitis and non-meningitis.

Strains of Klebsiella spp., E. coli, Proteus mirabilis that produce extended-spectrum beta-lactamase (ESBLs) may be clinically resistant to therapy with penicillins, cephalosporins, or aztreonam, despite apparant in vitro susceptibility to some of these agents. ESBL screening data reported from one laboratory showed 2.3% of E. coli/Klebsiella spp./Proteus mirabilis produced ESBLs. The rate of carbapenem-resistant enterobacteriaceae (CRE) was 0.7% (26/3879) in 2009. An enhanced surveillance for CRE began in June 2010 and is ongoing in Washoe County.

The rate of vancomycin-resistant enterococci (VRE) increased from 9.8% in 2002 to 11.6% in 2007, which showed a statistical significance (X2 = 65, P<0.001). The VRE rate was 11.9% in 2009, no statistical difference compared to 11.6% in 2007 (X2=0.0255, P=0.87)

The rate of Methicillin-resistant Staphylococcus aureus (MRSA) significantly increased from 35% in 2002 to 48% in 2007, a 37% increase from 2002 to 2007, which showed a statistical significance (X2 = 145, P<0.001). The MRSA rate was 47% in 2009, no statistical difference compared to 48% in 2007 (X2=0.8545, P=0.36).

Vancomycin-intermediate resistant Staphylococcus aureus (VISA) or Vancomycin-resistant Staphylococcus aureus (VRSA) has not been found yet in Washoe County. Please report VISA or VRSA to the Washoe County Health District at 775-328-2447. Please also have your laboratory save the VISA/VRSA isolate for further confirmation at Nevada State Public Health Laboratory.

VRE

MRSA

VISA / VRSA

P. aeruginosa

0

20

40

60

80

100

Ak Caz Cpm Gm Imp Lvx P/T To

2002 (1097)

2003 (1180)

2004 (1042)

2006 (742)

2007 (427)

2009 (580)

S. maltophilia

0

20

40

60

80

100

Ak Caz Gm Lvx To T/S

2002 (66)

2003 (109)

2004 (44)

2006 (31)

2007 (41)

2009 (42)

S. marcescens

0

20

40

60

80

100

Am Cfz Cp Cpm Gm Imp P/T To T/S

2002 (157)

2003 (152)

2004 (118)

2006 (93)

2007 (43)

2009 (70)

E. feacalis

020

406080

100

P E Fd Te Van

2002 (1282)

2003 (1517)

2004 (1147)

2006 (555)

2007 (607)

2009 (748)

E. faecium

0

20

40

60

80

100

P E Fd Te Van

2002 (254)

2003 (230)

2004 (216)

2006 (118)

2007 (131)

2009 (162)

S. aureus

0

20

40

60

80

100

Cfz Cd E Gm Lvx Ox P Te T/S Van

2002 (3059)2003 (3440)2004 (3660)2006 (4369)2007 (2030)2009 (2033)

S. coagulase neg.

0

20

40

60

80

100

Cfz Cd E Gm Lvx Ox P Te T/S Van

2002 (272)

2003 (226)

2004 (336)

2006 (414)

2007 (33)

2009 (31)

S. epidermidis

0

20

40

60

80

100

Cfz Cd E Gm Lvx Ox P Te T/S Van

2002 (1004)

2003 (1002)

2004 (800)

2006 (430)

2007 (372)

2009 (411)

S. pneumoniae

0

20

40

60

80

100

Cft E Gat P Van

2002 (301)

2003 (308)

2004 (297)

2006 (185)

2007 (184)

2009 (224)

C. freundii

0

20

40

60

80

100

Am Cfz Cp Cpm Gm Imp P/T To T/S

2002 (144)

2003 (211)

2004 (165)

2006 (139)

2007 (39)

2009 (44)

E. aerogenes

0

20

40

60

80

100

Am Cfz Cp Cpm Gm Imp P/T To T/S

2002 (140)2003 (191)2004 (165)2006 (110)2007 (32)2009 (68)

E. cloacae

0

20

40

60

80

100

Am Cfz Cp Cpm Gm Imp P/T To T/S

2002 (362)2003 (361)2004 (318)2006 (306)2007 (118)2009 (153)

E. coli

0

20

40

60

80

100

Am Cfz Cp Cpm Gm Imp P/T To T/S

2002 (6018)2003 (6796)2004 (7697)2006 (8040)2007 (2482)2009 (2717)

K. oxytoca

0

20

40

60

80

100

Am Cfz Cp Cpm Gm Imp P/T To T/S

2002 (205)2003 (193)2004 (157)2006 (119)2007 (87)2009 (92)

K. pneumoniae

0

20

40

60

80

100

Am Cfz Cp Cpm Gm Imp P/T To T/S

2002 (705)

2003 (1272)2004 (1125)

2006 (1236)

2007 (463)2009 (578)

M. morganii

0

20

40

60

80

100

Am Cfz Cp Cpm Gm Imp P/T To T/S

2002 (56)

2003 (72)

2004 (65)

2006 (35)

2007 (NA)

2009 (NA)

P. mirabilis

0

20

40

60

80

100

Am Cfz Cp Cpm Gm Imp P/T To T/S

2002 (285)2003 (455)2004 (452) 2006 (503)2007 (121)2009 (189)

A. baumanii

0

20

40

60

80

100

Ak Caz Cax Cp Gm Imp To T/S

2002 (NA)

2003 (NA)

2004 (NA)

2006 (32)

2007 (136)

2009(28)

RESULTRESULT

Antibiogram is an overall profile of antimicrobial susceptibility of a microbial species to a battery of antimicrobial agents. One of the 12 steps to prevent antimiobial resistance in various healthcare settings recommended by CDC is to encourage clinicians to use local data. Since 2002, Washoe County Health District (WCHD) has been collaborating with local laboratories to produce an aggregated community-wide antibiogram every year. Antibiogram has been well received by local medical community. The objectives of this paper are:

to summarize findings on major drug resistant organism such as Methicillin-resistant staphylococcus aureus(MRSA), Vancomycin-resistant enterococci (VRE), drug-resistant streptococcus pneumoniae (DRSP),extended-spectrum beta-lactamase (ESBLs), and carbapenem resistant enterobacteriaceae (CRE);

to present detailed antibiotic susceptibility data and their trends on 18 commonly seen organisms inhealthcare setting for 2002-2009.

BACKGROUNDBACKGROUND

Between 2002 and 2006, WCHD collected institutional antibiograms from local laboratories every year. Between 2007 and present, only local clinical laboratories provided such data. An excel template was developed for each organism to covert susceptibility percent to the number of isolates susceptible and then aggregate them together to produce an overall antibiotic susceptibility percentage. Number of isolates tested less than 10 was excluded fromdata conversion process. Aggregated number of isolates less than 30 was excluded from final calculation and therefore not reported. All isolates reported represented inpatients seen in local hospitals and outpatients seen in emergency departments. The resistance rate comparison between years was assessed by Chi-square statistics using OpenEpi Program.

METHODSMETHODS

The antibiotic resistant rate increased significantly between 2002 and 2007 but was stable between 2007 and 2009. The rates of ESBLs and CRE were low in Washoe County.

CONCLUSIONSCONCLUSIONS